Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Invention and High-Risk, High-Benefit Research

McGill University

$191,400.00

Regulation of adipogenesis by osteocalcin

FY 2009-10

Summary
Obesity, a condition where abnormally high fat accumulation occurs, is a worldwide epidemic and a leading preventable cause of death in the world. Obesity has increased dramatically over the years and in 2004, over 4.5 million Canadians (close to 15%) were obese. Childhood obesity is highly prevalent, in 2004 more than half a million, 2-17 year olds were obese. Obesity is a well-known risk factor for many severe diseases including type II diabetes, coronary heart disease, arthritis and cancer, and as such, it puts a massive burden on the Canadian health care system. Obesity is complex condition and a consequence of lifestyle choises, nutritional and genetic factors. In addition to factors, such as fat-promoting sedatary lifestyle and high fat foods, many genetic factors have been discovered that are linked weight gain and obesity. This grant focuses on a newly discovered genetic fat accumulation determinant, osteocalcin, which derives from the skeleton and bone cells and is eventually released to circulation. Mice, that have been engineered not to have osteocalcin protein, have unusual amount of fat deposition and it is thought that the function of osteocalcin is to regulate the balance between bone mass and body fat mass. This grant investigates the direct effects of osteocalcin on fat cells and was inspired by our current and previous results that suggest that osteocalcin could act as an inhibitor of a class of enzymes called transglutaminases. The results from our studies will improve our understanding of factors leading to weight gain and obesity and will elaborate on mechanisms at cellular level how fat accumulation could be regulated. This cellular level knowledge opens options to design treatments that could specifically target fat cell activity.
Program
Catalyst Grant: Invention and High-Risk, High-Benefit Research
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
203297
Name
Kaartinen Mari T
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Inventions, Technologies, or High Risk Grants
Projecttitle
Regulation of adipogenesis by osteocalcin
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$191,400
Cihrequipment2
$0
Programname2
Catalyst Grant: Invention and High-Risk, High-Benefit Research
Keyworddelim
Adipogenesis; Cell Adhesion; Fibronectin; Matrix Biology; Metabolic Disease; Obesity; Osteocalcin; Transglutaminases
Abstract
Obesity, a condition where abnormally high fat accumulation occurs, is a worldwide epidemic and a leading preventable cause of death in the world. Obesity has increased dramatically over the years and in 2004, over 4.5 million Canadians (close to 15%) were obese. Childhood obesity is highly prevalent, in 2004 more than half a million, 2-17 year olds were obese. Obesity is a well-known risk factor for many severe diseases including type II diabetes, coronary heart disease, arthritis and cancer, and as such, it puts a massive burden on the Canadian health care system. Obesity is complex condition and a consequence of lifestyle choises, nutritional and genetic factors. In addition to factors, such as fat-promoting sedatary lifestyle and high fat foods, many genetic factors have been discovered that are linked weight gain and obesity. This grant focuses on a newly discovered genetic fat accumulation determinant, osteocalcin, which derives from the skeleton and bone cells and is eventually released to circulation. Mice, that have been engineered not to have osteocalcin protein, have unusual amount of fat deposition and it is thought that the function of osteocalcin is to regulate the balance between bone mass and body fat mass. This grant investigates the direct effects of osteocalcin on fat cells and was inspired by our current and previous results that suggest that osteocalcin could act as an inhibitor of a class of enzymes called transglutaminases. The results from our studies will improve our understanding of factors leading to weight gain and obesity and will elaborate on mechanisms at cellular level how fat accumulation could be regulated. This cellular level knowledge opens options to design treatments that could specifically target fat cell activity.
Competitiondate
201003
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Kaartinen, Mari T
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $191,400~ $0~
McGill University - $191,400 Grant (2009-10) | Canada Spends